Helaina's precision fermentation platform replicates functional proteins found in the human body, making them available as new nutrients.
Helaina is a biotech company that replicates functional proteins found in the human body making them available as new nutrients. Their first protein is EfferaTM Human Lactoferrin. Preclinical and clinical research shows promise for Lactoferrin to support optimizing iron utilization, healthy gut function, healthy inflammatory response and maintaining a healthy immune system.
Helaina was founded in 2019 on the premise that nutrients must be more impactful and multifunctional for all people and the planet. Helaina’s technology platform powers a bioactive protein pipeline that will advance human healthspan. Helaina’s bioactive proteins will become a new category of nutrients.
The company completed its first clinical study on Effera’sTM in 2023
Helaina was selected as NutraIngredients Sports and Active Nutrition Startup Star 2024, IFT First Start Up Pitch Winner (2023)
To date Helaina has raised more $35M from leading investors
